相似文献
1
Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients.
In Vivo. 2020 Jun;34(3 Suppl):1661-1665. doi: 10.21873/invivo.11958.
2
Breast Cancer and COVID-19: The Effect of Fear on Patients' Decision-making Process.
In Vivo. 2020 Jun;34(3 Suppl):1651-1659. doi: 10.21873/invivo.11957.
3
Breast Cancer Surgery During the COVID-19 Pandemic: An Observational Clinical Study of the Breast Surgery Clinic at Ospedale Policlinico San Martino - Genoa, Italy.
In Vivo. 2020 Jun;34(3 Suppl):1667-1673. doi: 10.21873/invivo.11959.
4
Breast cancer surgery during the Covid-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome.
J Exp Clin Cancer Res. 2020 Aug 27;39(1):171. doi: 10.1186/s13046-020-01683-y.
5
Breast imaging and cancer diagnosis during the COVID-19 pandemic: recommendations from the Italian College of Breast Radiologists by SIRM.
Radiol Med. 2020 Oct;125(10):926-930. doi: 10.1007/s11547-020-01254-3. Epub 2020 Jul 13.
6
Breast cancer care during a pandemic: an opportune time for cryoablation?
Breast Cancer Res Treat. 2020 Aug;182(3):515-521. doi: 10.1007/s10549-020-05724-0. Epub 2020 Jun 11.
7
Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST).
Breast. 2020 Aug;52:110-115. doi: 10.1016/j.breast.2020.05.006. Epub 2020 May 29.
8
Breast Surgery in the Time of Global Pandemic: Benefits of Same-Day Surgery for Breast Cancer Patients Undergoing Mastectomy with Immediate Reconstruction during COVID-19.
Plast Reconstr Surg. 2020 Oct;146(4):522e-523e. doi: 10.1097/PRS.0000000000007269.
9
In situ breast cancer: a multidisciplinary approach.
Hosp Pract (Off Ed). 1989 Apr 15;24(4):169-76, 179-85. doi: 10.1080/21548331.1989.11703702.
10
[Breast cancer management during the COVID 19 pandemic: The CNGOF takes action].
Gynecol Obstet Fertil Senol. 2020 Jun;48(6):473-474. doi: 10.1016/j.gofs.2020.04.008. Epub 2020 Apr 19.
引用本文的文献
1
Did the Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Breast Cancer Patients?
Cureus. 2024 Aug 9;16(8):e66501. doi: 10.7759/cureus.66501. eCollection 2024 Aug.
2
Socioeconomic Impact of OncotypeDX on Breast Cancer Treatment: Preliminary Results.
In Vivo. 2023 Nov-Dec;37(6):2510-2516. doi: 10.21873/invivo.13358.
3
Exploring hematic crasis variations in cancer patients following SARS-CoV-2 vaccination: a real-practice study.
Infect Agent Cancer. 2023 Oct 17;18(1):62. doi: 10.1186/s13027-023-00532-9.
4
Therapy delay due to COVID-19 pandemic among European women with breast cancer: prevalence and associated factors.
J Cancer Res Clin Oncol. 2023 Oct;149(13):11749-11757. doi: 10.1007/s00432-023-05065-7. Epub 2023 Jul 5.
5
From Patient Reported Outcome Measure (PROM) to Environment Related Outcome Measure (EROM): Towards "Green Breast Surgery".
In Vivo. 2023 Jul-Aug;37(4):1867-1872. doi: 10.21873/invivo.13278.
6
Awake Breast Surgery: A Systematic Review.
In Vivo. 2023 Jul-Aug;37(4):1412-1422. doi: 10.21873/invivo.13225.
7
Changes in Breast Cancer Presentation during COVID-19: Experience in an Urban Academic Center.
Int J Breast Cancer. 2023 Jun 9;2023:6278236. doi: 10.1155/2023/6278236. eCollection 2023.
8
Consequences of the impact of COVID-19 pandemic on breast cancer at a single Italian institution.
Explor Target Antitumor Ther. 2022;3(4):414-422. doi: 10.37349/etat.2022.00091. Epub 2022 Jul 29.
9
Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.
In Vivo. 2022 Mar-Apr;36(2):853-858. doi: 10.21873/invivo.12773.
10
The Impact of the SARS-CoV-2 Pandemic on Healthcare Provision in Italy to non-COVID Patients: a Systematic Review.
Mediterr J Hematol Infect Dis. 2022 Jan 1;14(1):e2022012. doi: 10.4084/mjhid.2022.012. eCollection 2022.
本文引用的文献
1
Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery.
In Vivo. 2020 May-Jun;34(3):1125-1132. doi: 10.21873/invivo.11884.
2
Risk of COVID-19 for patients with cancer.
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
3
Evaluation of Ultrasound-guided 8-Gauge Vacuum-assisted Excision System for the Removal of US-detectable Breast Lesions.
Anticancer Res. 2020 Mar;40(3):1719-1729. doi: 10.21873/anticanres.14125.
4
[Medical diagnosis and treatment strategies for malignant tumors of the digestive system during the outbreak of COVID-19].
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):184-186. doi: 10.3760/cma.j.cn112152-20200227-00141.
5
[Health management of breast cancer patients outside the hospital during the outbreak of 2019 novel coronavirus disease].
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):288-291. doi: 10.3760/cma.j.cn112152-20200221-00110.
6
[The treatment proposal for the patients with breast diseases in the central epidemic area of 2019 coronavirus disease].
Zhonghua Wai Ke Za Zhi. 2020 May 1;58(5):331-336. doi: 10.3760/cma.j.cn112139-20200221-00116.
7
[Treatment strategy for gastrointestinal tumor under the outbreak of novel coronavirus pneumonia in China].
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Feb 25;23(2):I-IV. doi: 10.3760/cma.j.issn.1671-0274.2020.02.001.
8
Reducing the Number of Unnecessary Percutaneous Biopsies: The Role of Second Opinion by Expert Breast Center Radiologists.
Anticancer Res. 2020 Feb;40(2):939-950. doi: 10.21873/anticanres.14027.
9
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges.
Ann Oncol. 2020 Jan;31(1):61-71. doi: 10.1016/j.annonc.2019.10.012.
10
Evaluation of Concordance Between Histopathological, Radiological and Biomolecular Variables in Breast Cancer Neoadjuvant Treatment.
Anticancer Res. 2020 Jan;40(1):281-286. doi: 10.21873/anticanres.13950.
Zotero 插件